Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples

Benchmark 03 medical and health sciences SDG 3 - Good Health and Well-being info:eu-repo/classification/ddc/616 Virology Viral metagenomics Humans ddc:616 0303 health sciences Science & Technology ENCEPHALITIS Bioinformatic pipelines Computational Biology High-Throughput Nucleotide Sequencing 2725 Infectious Diseases 3. Good health ALIGNMENT Benchmarking Infectious Diseases Viruses 2406 Virology 570 Life sciences; biology Metagenomics Life Sciences & Biomedicine 10244 Institute of Virology
DOI: 10.1016/j.jcv.2021.104908 Publication Date: 2021-07-08T17:52:41Z
ABSTRACT
Metagenomic sequencing is increasingly being used in clinical settings for difficult to diagnose cases. The performance of viral metagenomic protocols relies a large extent on the bioinformatic analysis. In this study, European Society Clinical Virology (ESCV) Network NGS (ENNGS) initiated benchmark pipelines currently virological laboratories.Metagenomic datasets from 13 samples patients with encephalitis or respiratory infections characterized by PCR were selected. analyzed different diagnostic laboratories participating ENNGS members. and classification tools were: Centrifuge, DAMIAN, DIAMOND, DNASTAR, FEVIR, Genome Detective, Jovian, MetaMIC, MetaMix, One Codex, RIEMS, VirMet, Taxonomer. Performance, characteristics, use, user-friendliness these analyzed.Overall, pathogens high loads detected all evaluated pipelines. contrast, lower abundance mixed only 3/13 pipelines, namely MetaMix. Overall sensitivity ranged 80% (10/13) 100% (13/13 datasets). positive predictive value 71-100%. majority classified sequences based nucleotide similarity (8/13), minority amino acid similarity, 6 assembled de novo. No clear differences that correlated approaches. Read counts target viruses varied between over range 2-3 log, indicating limit detection.A wide variety laboratories. Detection low abundant remains challenge, implicating need standardization validation analysis use. Future studies should address selective effects due choice reference databases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (55)
CITATIONS (50)